Coming back to something from earlier in the thread, because it keeps being talked past:
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
Following on from LipidDoc_ATL — and this may be the naive question:
What would you measure differently if you were starting again?
Reporting back.
I held the step an extra three weeks instead of stepping back down, and it settled. Same dose, same everything, just more time — which is exactly what was suggested upthread.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsDoseLogDan said:Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.
Worth separating that from the titration schedule, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.
DoseLogDan said:Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
Bookmarking. The distinction being drawn above is the one nobody else makes.